Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
POOR LONG-TERM OUTCOME OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN NONPROLIFERATIVE MACULAR TELANGIECTASIA TYPE 2.
Retina. 2015 Dec;35(12):2619-26. doi: 10.1097/IAE.0000000000000715.
Retina. 2015.
PMID: 26340529
Treatment for Macular Telangiectasia Type 2.
Charbel Issa P, Kupitz EH, Heeren TF, Holz FG.
Charbel Issa P, et al. Among authors: kupitz eh.
Dev Ophthalmol. 2016;55:189-95. doi: 10.1159/000431263. Epub 2015 Oct 26.
Dev Ophthalmol. 2016.
PMID: 26501828
Review.
Item in Clipboard
VERY EARLY DISEASE MANIFESTATIONS OF MACULAR TELANGIECTASIA TYPE 2.
Charbel Issa P, Heeren TF, Kupitz EH, Holz FG, Berendschot TT.
Charbel Issa P, et al. Among authors: kupitz eh.
Retina. 2016 Mar;36(3):524-34. doi: 10.1097/IAE.0000000000000863.
Retina. 2016.
PMID: 26618805
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.